PGY-2 Oncology Residency | Department of Pharmacy Services | UC Davis Health

Residency Program Director

Program Overview

The Oncology Pharmacy Pharmacy Residency at the University of California, Davis Medical Center, is a one-year, PGY2 residency in Oncology Pharmacy Practice. The residency is supported by the Department of Pharmacy.

Oncology is a strong, well-established and progressive center of excellence at UC Davis Health. The UC Davis Cancer Center is a Comprehensive Cancer Center, as designated by the National Cancer Institute. Clinical Pharmacy Services at UC Davis Health are provided in the areas of medical oncology, hematology, cellular therapy, pediatric oncology, investigational drugs service and at the UC Davis Comprehensive Cancer Center Infusion Rooms and clinics. The oncology specialty residency will provide residents with a comprehensive training and educational experience in oncology pharmacy.

UC Davis Health Pharmacy Department Mission

UC Davis Health Pharmacy's mission is to provide the highest quality and most cost-effective pharmaceutical care in an environment that fosters efficient patient-focused care, education and research. Pharmaceutical care services are designed to meet the needs of our customers (primarily patients, nurses and physicians) in a way that constructively impacts all aspects of the medication use process (assessing, prescribing, dispensing, administering and monitoring). We will be flexible and proactive in our responsiveness to opportunities and challenges in the dynamic health-care field.

UC Davis Health PGY2 Oncology Pharmacy Residency Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency training to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives for advanced practice areas. Residents who successfully complete PGY2 residency programs are prepared for advanced patient care or other specialized positions, and board certification in the advanced practice area, if applicable. The purpose of the PGY2 Oncology Residency Program is to provide the PGY2 oncology residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete the PGY2 Oncology pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification in oncology pharmacy.

The aim of the UC Davis PGY2 Oncology Pharmacy Residency is to train oncology pharmacists to provide high quality, evidence-based, cost-effective, specialty care to patients with cancer and hematologic disorders in a positive learning environment that promotes independent, critical thinking, creativity and a culture of mutual respect.

Program Design

The major area of focus is adult hematology and oncology, with an emphasis on supportive care, antineoplastic drug pharmacology, management of patients with malignant and hematologic disorders, cellular therapies, investigational cancer therapies, prevention and management of antineoplastic drug toxicities and medication safety in oncology pharmacy practice. Oncology patient care is provided in multidisciplinary settings, and oncology pharmacy residents will interact with clinical pharmacists, pharmacy technicians, physicians, nurses, discharge planners, dietitians, patients, and caregivers to provide comprehensive care to patients with cancer. Daily activities will include coordinating cancer treatment plans, chemotherapy preparation and administration activities, preventive and supportive management of cancer treatment-related complications, providing drug information to physicians, nurses and patients, medication reconciliation and coordination of home and discharge medications.

The UC Davis Health PGY2 Oncology Residency is designed to meet the educational goals and objectives, as outlined by ASHP and the ASHP Accreditation Standard.

Program Structure

The PGY2 Oncology Residency is a full-time, 52-week residency program, beginning on July 1 and ending on June 30. Clearance to start work by UC Davis Health Employee Health and Human Resources must be completed prior to the established residency start date.

UC Davis Health PGY2 Oncology Residency Learning Experiences:
The residency learning experiences will primarily be divided into block rotations and longitudinal learning experiences. The majority of rotations will be 4 weeks in duration. Rotation schedules will be determined based on availability and resident interests. Schedules will be adjusted and updated with the resident at each quarterly development plan meeting.

Case Conference/ Topic Content:
The UC Davis Health PGY2 Oncology Residency is designed to provide the resident with a broad range of experiences in a variety of practice settings. Required learning experiences have been designed to meet the appendix content requirements, as outlined by ASHP. A content checklist and patient tracker is provided to each resident to document exposure to the required content and patient experiences. Residents will also maintain a list of patients tracked in the UC Davis Health electronic medical record to maintain PHI. This activity will be documented in PharmAcademic as a longitudinal learning experience and progress will be reviewed quarterly with each resident as part of their individual development plans.

UC Davis Health PGY2 Oncology Resident’s Role in Teaching:
UC Davis Health offers many opportunities for both clinical and didactic teaching. The resident will be responsible for assisting preceptors with clerkship teaching for University of California, San Francisco pharmacy students and UC Davis Health PGY1 pharmacy residents during various learning experiences.

The resident will be required to prepare an ACPE accredited pharmacy grand rounds presentation on an oncology topic, based on the resident’s interests and a department needs assessment. The PGY2 Oncology Resident will also have the opportunity to participate in and lead didactic teaching as well as journal club discussions with the other student and resident learners.

Residency Research Project:
All UC Davis Health PGY2 residents are required to complete a research project during their residency and present their research at a regional, state or national conference. In preparation for conducting their research project, the resident will complete UC Davis Health IRB-required training and certification. The resident will prepare a project proposal, which will be reviewed and approved by the UC Davis Health Pharmacy Research Oversight Committee. The resident will also submit their project to the Pharmacy and Therapeutics Oncology Sub-Committee and the IRB for approval, before embarking on their research. The resident will also be provided opportunities to present their research at one or more regional pharmacy residency conferences and submit their project as a poster presentation at a national pharmacy meeting (e.g. HOPA). Upon completion of the project, the resident will be required to summarize their research project in a manuscript suitable for submission to a journal for publication.

Pharmacy and Therapeutics Committee Activity:
The PGY2 Oncology resident will be required to participate in the Oncology Sub-Committee of the UC Davis Health Pharmacy and Therapeutics Committee. The resident will also be required to complete the following activities for Oncology Sub-Committee:

1. New oncology drug review/monograph
2. MUE on oncology/supportive medication use or oncology guideline update

Additional assignments will be determined by the RPD in collaboration with the UC Davis Health P&T Committee coordinator, based on the resident’s interests, and the needs of the committee.

Committee Assignments:
The PGY2 Oncology residents will rotate in quarterly assignments on the following UC Davis Health Committees: 1) Oncology Sub-Committee 2) BMT CQI Committee 3) UC Oncology Collaborative Committee 4) UCDCCC Scientific Research Committee. The resident will be assigned various activities during each committee rotation. Activities may include specific projects, coordinating agendas and minutes, reviewing documents and maintaining/updating the UC Davis Health Hazardous Drugs Inventory. The purpose of the resident’s committee involvement is to ensure the resident gains exposure to the oncology pharmacist’s role in activities related to quality-improvement, medication safety, safe handling of hazardous drugs, guideline development and assessment/implementation of technology and automation within the institution and pharmacy department.

Professional Development:
The PGY2 oncology resident is encouraged to maintain an active role in pharmacy and oncology professional organizations. The resident is strongly encouraged to become a member of the Hematology Oncology Pharmacists Association (HOPA) and attend their annual meeting in the early Spring. The resident will be provided with some financial supporta travel stipend from the institution and professional leave time to facilitate participation in professional development activities.

The PGY2 Oncology residents will also participate in the Northern California Oncology Pharmacy Network (NCOPN). This is a regional oncology pharmacy group that offers the residents to interact with our PGY2 Oncology Pharmacy residents and pharmacists from California, As part of this group, the residents will be required to present a journal club article of case presentation at one of the regular virtual meetings. Additionally, the residents will present their oncology research projects that the annual NCOPN Forum which is typicallys scheduled about 3-4 weeks in advance of the Annual HOPA Annucal Conference.

Pharmacy Department Service:
The PGY2 oncology resident will be expected to provide ~400 hours of pharmacy department service. This expectation will be met primarily by providing oncology pharmacist coverage every third weekend plus one major holiday (Thanksgiving, Christmas, or New Year’s), at least one minor holiday and ~15 shifts of evening Oncology support A back-up oncology pharmacist will always be available on site or on-call, to advise and support the PGY2 Oncology Pharmacy resident as needed.

Required Competencies:
Residents function as licensed pharmacists in patient care activities. As such, minimum knowledge in a variety of areas must be assured. Within one month of starting the Residency, the resident must complete competencies required of all clinical pharmacists.

Resident Portfolio:
Each resident must maintain a portfolio containing all information from the residency year including but not limited to: required deliverables to document successful residency completion, copies of papers or projects done during rotations, lectures given, research project manuscript, P&T drug monograph, and MUE. The portfolio shall be maintained in Pharm Academic and/or in the resident’s folder on the Pharmacy Department shared drive.

Benefits:
Health, Dental and Vision insurance for resident and dependents; vacation, sick leave and professional leave as outlined in the Pharmacy Resident Manual, usually 21 days of PTO, 14 paid holidays, 6 extended sick days and 4 days of professional development leave. Travel funds (~$3000) are included in the base salary. There is a stipend for Pharmacy Department scrubs.

Resident Personnel Policies:
The following policies can be located in the Pharmacy Resident Personnel Manual

• Resident Qualifications
• Licensure policy
• Leave policies
• Early Commitment Policy
• Pre-employment drug testing
• Health insurance and Benefits
• Moonlighting
• Duty hours/tracking of duty hours
• Dismissal policy and consequences of failure to progress

Criteria for Successful Completion of the PGY2 Oncology Residency

• California Pharmacist Licensure per Pharmacy Resident Manual Policy
• A minimum of 52 weeks of training inclusive of standard vacation, professional and sick leave.
• Successful completion of all required rotations/learning experiences
  • No outstanding “Needs Improvement” on any required rotation goals or objectives
  • Minimum of 80% of objectives marked as “Achieved” by the end of the residency year
  • Achievement of 100% of Patient Care Competency Area (R1) objectives
• Resident closeout completed in PharmAcademic, confirming all tasks are completed
• Completion of required items on the Oncology Residency Content (topic discussion) Checklist and Patient Tracker
• Completed staffing requirements as outlined by the residency program description
• Completion of deliverables for Competency Area Goals and Objectives (CAGO) requirements (see table, below):

Pharmacy Residency training programs at UC Davis Health are conducted under the licensed entity within UC Davis Health which is UC Davis Medical Center.